SREBF2 and hepatocellular carcinoma: Emerging evidence implicates dysregulated lipid metabolism, particularly sterol regulatory element-binding protein 2 (SREBP2), in HCC progression, yet its prognostic role in post-LT recurrence remains unexplored.